First Trust Advisors’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-56,438
Closed -$328K 2556
2019
Q1
$328K Buy
56,438
+34,274
+155% +$354K ﹤0.01% 2250
2018
Q4
$298K Buy
+22,164
New +$374K ﹤0.01% 2265
2018
Q3
Sell
-18,881
Closed -$483K 2573
2018
Q2
$483K Buy
18,881
+1,759
+10% +$41K ﹤0.01% 2163
2018
Q1
$345K Buy
17,122
+627
+4% +$14.6K ﹤0.01% 2119
2017
Q4
$331K Sell
16,495
-58,955
-78% -$1.16M ﹤0.01% 2210
2017
Q3
$1.56M Buy
75,450
+4,327
+6% +$73.2K ﹤0.01% 1632
2017
Q2
$1.05M Buy
71,123
+15,574
+28% +$260K ﹤0.01% 1826
2017
Q1
$886K Buy
55,549
+9,362
+20% +$135K ﹤0.01% 1886
2016
Q4
$582K Sell
46,187
-5,047
-10% -$94K ﹤0.01% 2060
2016
Q3
$1.44M Buy
51,234
+26,836
+110% +$901K ﹤0.01% 1523
2016
Q2
$854K Buy
+24,398
New +$767K ﹤0.01% 1775
2016
Q1
Sell
-46,505
Closed -$1.59M 2326
2015
Q4
$1.59M Buy
46,505
+575
+1% +$17.9K ﹤0.01% 1521
2015
Q3
$1.32M Buy
45,930
+4,140
+10% +$177K ﹤0.01% 1612
2015
Q2
$1.87M Buy
+41,790
New +$1.57M ﹤0.01% 1581
2015
Q1
Sell
-27,341
Closed -$748K 2335
2014
Q4
$748K Buy
+27,341
New +$663K ﹤0.01% 1842

Other funds holding DPLO

First Trust Advisors's DPLO Position: Q2 2019 in Review

First Trust Advisors sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q2 2019, closing a stake of 56,438 shares — an estimated $328K sold.

First Trust Advisors first reported a position in DPLO in Q4 2014 and held it in 15 quarters. The position peaked at $1.87M in Q2 2015. 131 funds tracked by Wall St. Rank hold DPLO as of Q2 2019.

  • First Trust Advisors reported no remaining DIPLOMAT PHARMACY, INC. position as of Q2 2019 after selling out during the quarter.
  • First Trust Advisors sold 56,438 DIPLOMAT PHARMACY, INC. shares in Q2 2019, an estimated $328K.
  • First Trust Advisors first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and held it in 15 quarters.
  • First Trust Advisors's DIPLOMAT PHARMACY, INC. position peaked at $1.87M in Q2 2015.
  • 131 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q2 2019.

Based on First Trust Advisors's 13F filing for Q2 2019, filed 30 Jul 2019.